Insider · CIK 0001700449

Arix Bioscience plc

Reports to the SEC for 3 companies · MAYFAIR, LONDON, X0

sec.gov

Transactions

Companies

Filings

CIK

0001700449

Forms 4 and 5

Insider transactions

29 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2020-09-28	LogicBio Therapeutics, Inc.S Sale	10% Owner	SSale	−274K sh	$7.54	−$2.06M	2,381,436
2020-09-25	LogicBio Therapeutics, Inc.S Sale	10% Owner	SSale	−174K sh	$7.08	−$1.23M	2,655,020
2020-09-24	LogicBio Therapeutics, Inc.S Sale	10% Owner	SSale	−38.5K sh	$7.63	−$294K	2,829,239
2020-08-13	LogicBio Therapeutics, Inc.S Sale	10% Owner	SSale	−159 sh	$8.75	−$1,391.25	2,867,753
2020-08-12	LogicBio Therapeutics, Inc.S Sale	10% Owner	SSale	−1,335 sh	$8.79	−$11.7K	2,867,912
2020-07-29	LogicBio Therapeutics, Inc.S Sale	10% Owner	SSale	−2,709 sh	$8.78	−$23.8K	2,869,247
2020-07-22	LogicBio Therapeutics, Inc.S Sale	10% Owner	SSale	−22.7K sh	$9.00	−$204K	2,871,956
2020-07-20	LogicBio Therapeutics, Inc.S Sale	10% Owner	SSale	−37K sh	$9.25	−$342K	2,894,607
2020-07-17	LogicBio Therapeutics, Inc.S Sale	10% Owner	SSale	−31.1K sh	$9.24	−$287K	2,931,590
2020-07-16	LogicBio Therapeutics, Inc.S Sale	10% Owner	SSale	−16.3K sh	$8.56	−$140K	2,962,691
2020-05-28	Harpoon Therapeutics, Inc.S Sale	10% Owner	SSale	−367K sh	$21.33	−$7.82M	2,193,704
2020-05-27	Harpoon Therapeutics, Inc.S Sale	10% Owner	SSale	−12.1K sh	$22.39	−$270K	2,560,295
2020-03-16	ELVNEnliven Therapeutics, Inc.C Conversion	10% Owner	CConversion	+1.37M sh	—	—	1,367,058
2020-03-16	ELVNEnliven Therapeutics, Inc.P Purchase	10% Owner	PPurchase	+188K sh	$16.00	+$3M	1,554,558
2020-03-16	ELVNEnliven Therapeutics, Inc. · Series B Preferred StockC Conversion	10% Owner	CConversion	−8.61M sh	—	—	0
2019-12-17	Harpoon Therapeutics, Inc.S Sale	10% Owner	SSale	−12.5K sh	$16.83	−$210K	2,572,359
2019-12-16	Harpoon Therapeutics, Inc.S Sale	10% Owner	SSale	−13.1K sh	$17.02	−$223K	2,584,835
2019-12-13	Harpoon Therapeutics, Inc.S Sale	10% Owner	SSale	−11K sh	$17.21	−$189K	2,597,915
2019-12-10	Harpoon Therapeutics, Inc.S Sale	10% Owner	SSale	−132K sh	$16.91	−$2.23M	2,608,917
2019-12-09	Harpoon Therapeutics, Inc.S Sale	10% Owner	SSale	−26.4K sh	$18.30	−$484K	2,817,929
2019-12-09	Harpoon Therapeutics, Inc.S Sale	10% Owner	SSale	−77.3K sh	$18.12	−$1.4M	2,740,613
2019-12-06	Harpoon Therapeutics, Inc.S Sale	10% Owner	SSale	−47.8K sh	$19.15	−$914K	2,844,367
2019-02-12	Harpoon Therapeutics, Inc.Series C Convertible Preferred StockC Conversion	10% Owner	CConversion	−743K sh	—	—	0
2019-02-12	Harpoon Therapeutics, Inc.Series B Convertible Preferred StockC Conversion	10% Owner	CConversion	−1.72M sh	—	—	0
2019-02-12	Harpoon Therapeutics, Inc.P Purchase	10% Owner	PPurchase	+429K sh	$14.00	+$6M	2,892,119
2019-02-12	Harpoon Therapeutics, Inc.C Conversion	10% Owner	CConversion	+2.46M sh	—	—	2,463,548
2018-10-23	LogicBio Therapeutics, Inc.C Conversion	10% Owner	CConversion	+2.28M sh	—	—	2,279,023
2018-10-23	LogicBio Therapeutics, Inc.Series B Preferred StockC Conversion	10% Owner	CConversion	−4.35M sh	—	—	0
2018-10-23	LogicBio Therapeutics, Inc.P Purchase	10% Owner	PPurchase	+700K sh	$10.00	+$7M	2,979,023

Recent filings

Accepted (ET)
Oct 54
Arix Bioscience plc0000899243-20-027297
SEC(opens sec.gov)
May 294
Arix Bioscience Holdings Ltd0000899243-20-014559
SEC(opens sec.gov)
Mar 164
Arix Bioscience Holdings Ltd0000899243-20-008474
SEC(opens sec.gov)
Dec 174
Arix Bioscience plc0000899243-19-029473
SEC(opens sec.gov)
Dec 104
Arix Bioscience plc0000899243-19-028848
SEC(opens sec.gov)

Companies

Address

20 BERKELEY SQUARE

MAYFAIR, LONDON, X0, W1J 6EQ